Log in to your Inderes Free account to see all free content on this page.
Vicore Pharma Holding
10.36 SEK
+3.70 %
Less than 1K followers
VICO
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+3.70 %
-4.78 %
-13.95 %
+9.17 %
+22.60 %
+37.58 %
-55.63 %
-47.03 %
+105.15 %
Vicore Pharma operates in the pharmaceutical industry and focuses on the development of innovative treatments for pulmonary and cardiovascular diseases. The company researches new therapies that can improve patient outcomes and quality of life. The business is global with a primary presence in Europe and North America. Vicore Pharma was founded in 2000 and is headquartered in Gothenburg, Sweden.
Read moreMarket cap
2.92B SEK
Turnover
5.14M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27.2.
2026
Annual report '25
6.5.
2026
General meeting '26
6.5.
2026
Interim report Q1'26
All
Webcasts
Press releases
ShowingAll content types
Vicore to present at the DNB Carnegie Nordic Healthcare Conference
Vicore to present at the Jefferies Global Healthcare Conference in London
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio